The CDC panel voted against an ingredient that the anti-vaccine movement has long targeted, while Arcadia was acquired by ...

Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...

An mRNA-based seasonal flu vaccine from Moderna was 27 percent more effective at preventing influenza infections than a ...

The trial enrolled more than 40,800 adults 50 and older from 11 countries.

The Minister of Agriculture, John Steenhuisen, is pleased to announce that, in the coming days, South Africa will embark on its first-ever vaccination of poultry as a proactive measure to minimise the ...

"This is a very clear effort to shine a light on this anti-vaccine trope: that thimerosal is somehow dangerous.” ...

Today, a new ESC Clinical Consensus Statement published in the European Heart Journal discusses the key role of vaccination ...

The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

The preservative is in a small share of flu shots and has been studied for decades. Experts say it’s safe — despite Kennedy’s long opposition.

Moderna has reported positive phase 3 results for its seasonal flu vaccine, mRNA-1010, which outperformed a standard-dose ...

Moderna shares rose on the increased effectiveness of its flu vaccine in late-stage trials, bring the biotech company closer ...